Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.75 |
| ▸ | HPGD | P15428 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.75 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.63 |
| ▸ | JUN | P05412 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.61 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.61 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.61 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11584522 | 1.00 | KDM4E (0.75) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL2743877 | 0.87 | NFKB1 (0.79) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL30493821 | 0.87 | NFKB1 (0.79) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL2743876 | 0.87 | NFKB1 (0.79) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| O,O'-Dimethylcaffeic Acid SCHEMBL1659799 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| O,O'-Dimethylcaffeic Acid SCHEMBL1659802 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL8153885 | 0.86 | KDM4E (0.75) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| O,O'-Dimethylcaffeic Acid SCHEMBL81318 | 0.86 | KDM4E (1.00) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL4937158 | 0.86 | FDPS (0.79) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 | |
| SCHEMBL4937166 | 0.86 | FDPS (0.79) | KDM4EALDH1A1SMN1; SMN2HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | claimed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | claimed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | claimed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | claimed |
| EP-1765761-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | Gokaraju, Ganga, Raju (IN) | 2007-03-28 | — | — | EP | claimed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | claimed |
| WO-2005123649-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID | GOKARAJU GANGA RAJU (IN) | 2005-12-29 | — | — | WO | claimed |
| US-8748598-B2 | Analogs of 3-O-acetyl-11-keto-beta-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2014-06-10 | — | — | US | disclosed |
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | disclosed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| EP-1765761-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | Gokaraju, Ganga, Raju (IN) | 2007-03-28 | — | — | EP | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
| WO-2005123649-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID | GOKARAJU GANGA RAJU (IN) | 2005-12-29 | — | — | WO | disclosed |
| US-4101464-A | Process for preparing foamed solids using two or more azo compounds | PENNWALT CORPORATION (US) | 1978-07-18 | — | — | US | disclosed |
| US-3993609-A | ACID SENSITIVE AZO PROMOTERS | PENNWALT CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | NFKBIA, ALOX12, ALOX15 | KDM4E 3049/4885ALDH1A1 298/4885SMN1; SMN2 4370/4885 |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | KAT2B, AKR1C3, ACACB | KDM4E 2773/4885ALDH1A1 431/4885SMN1; SMN2 4129/4885 |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | ACACB, KAT2B, AKR1C3 | KDM4E 3024/4885ALDH1A1 378/4885SMN1; SMN2 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.